PL EN


Preferences help
enabled [disable] Abstract
Number of results
2008 | 56 | 3 | 181-191
Article title

The significance of Treg cells in defective tumor immunity

Title variants
Languages of publication
EN
Abstracts
EN
Regulatory T cells (Treg) enriched in FoxP3+, glucocorticoid-induced TNF receptor+, and cytotoxic T-lymphocyte-associated antigen-4+ exert a potential to suppress effector T cells in the periphery. These cells exist in markedly higher proportions within tumor-infiltrating lymphocytes, peripheral blood lymphocytes, and/or regional lymph node lymphocytes of patients with cancer and their frequencies are suggested to be strongly related to tumor progression and inversely correlated with the efficacy of treatment. Tumor-specific Treg cells require ligand-specific activation and cell-to-cell contact to exert their suppressive activity on tumor-specific effector cells (CD8+ cytotoxic T lymphocytes and CD4+ Th cells), which includes decreased cytotoxity, proliferation, and Th1 cytokine secrection. Depletion or blockade of Treg cells can enhance immune protection from tumor-associated antigens that are expressed as self antigens. Recent studies revealed that lymphoma T cells might adopt a Treg profile as well. Studies assessing the influence of chemotherapy on Treg cells have also been included in this review.
Publisher

Year
Volume
56
Issue
3
Pages
181-191
Physical description
Contributors
author
author
author
References
Document Type
REVIEW
Publication order reference
Agata Kosmaczewska, Department of Experimental Therapy, Institute of Immunology and Experimental Therapy, Polish Academy of Sciences, Weigla 12, 53-114 Wroclaw, Poland
Identifiers
YADDA identifier
bwmeta1.element.element-from-psjc-0c511e4f-9699-32c9-a079-6071f5e9e1b3
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.